FAQs | Kisaco Research

General

  • What is Pharma and Biotech Patent Litigation North America

    Pharma and Biotech Patent Litigation North America is the leading life sciences patent litigation event in the United States. Over two days, the agenda covers Hatch-Waxman and BPCIA disputes, skinny label case law review,  safe harbor updates, venue selection and judicial insights, while connecting 350+ IP leaders with 50% in-house counsel in attendance.

  • What Topics will be covered at Pat Lit NA

    The agenda spans the full spectrum of life sciences patent litigation, including Hatch-Waxman and BPCIA disputes, 505(b)(2) pathways, safe harbor updates, a review of skinny label outcomes post-Amarin v. Hikma, and insights from U.S. and European judges.

    To see the full list of topics, view our agenda here.

  • Is the summit taking place in person?

    To encourage collaboration and facilitate networking, Pharma and Biotech Patent Litigation North America will be fully in person. There is no virtual element of this conference

  • When and where is the summit?

    The summit takes place on September 15-16 at the Royal Sonesta Cambridge 40 Edwin H Land Blvd, Cambridge, MA 02142, United States

  • Who participates in the summit?
    For a detailed breakdown on previous speakers, partners, and attendee profiles, check out our who attends pages here.

Attending & Logistics